DelveInsight’s analysis estimates that the postherpetic neuralgia market is expected to show positive growth, mainly attributed to increased incidence and the anticipated launch of novel therapies during the forecasted period (2024–2034). LAS VEGAS, June 10, 2024 /PRNewswire/ –…